Clinical trial

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients

NCT06178627

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-08-13

PhasePHASE4

Study timeline

Study start (actual)2023-08-13Date precision: day

Registry last updated2023-12-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cryptococcal Meningitisunresolved

Antifungal Agentsunresolved

Interventions

Amphotericin B 0.5 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.DRUG

Amphotericin B 0.7 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.DRUG

Sponsors & collaborators

Huashan Hospitallead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06178627 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.